Amgen Enters Biosimilars Market with Watson Pharmaceuticals Collaboration

By Heather Cartwright

Pharma Deals Review: Vol 2012 Issue 1 (Table of Contents)

Published: 6 Jan-2012

DOI: 10.3833/pdr.v2012.i1.1644     ISSN: 1756-7874

Section: Licensing



Amgen and Watson Pharmaceuticals have formed a global collaboration to develop and commercialise biosimilar versions of oncology antibody therapeutics...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details